1 |
Yu C, Lin H, Chan MW, Chiou W, Lee M, Chi C, Lin R, Hsu F, Chen L, Chew C, Yang H, Hung S. IRAK2, an immune and radiation-response gene, correlates with advanced disease features but predicts high post-irradiation local control in resected oral cancer patients.. [DOI: 10.21203/rs.3.rs-2434157/v1] [Reference Citation Analysis]
|
2 |
Yu CC, Chan MWY, Lin HY, Chiou WY, Lin RI, Chen CA, Lee MS, Chi CL, Chen LC, Huang LW, Chew CH, Hsu FC, Yang HJ, Hung SK. IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell Carcinoma. Front Oncol 2021;11:647175. [PMID: 34249686 DOI: 10.3389/fonc.2021.647175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
3 |
Verma M, Kumar V. Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy. Resistance to Targeted Anti-Cancer Therapeutics 2019. [DOI: 10.1007/978-3-030-21477-7_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
4 |
Yan L, Zhan C, Wang S, Wang S, Guo L. Genetic analysis of radiation-specific biomarkers in sinonasal squamous cell carcinomas. Tumour Biol 2016;37:12001-9. [PMID: 27164935 DOI: 10.1007/s13277-016-5057-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|